Endo sews up $9.2B financing for Par Pharma buyout

Earlier this week, Endo ($ENDP) inked a pact to nab Par Pharmaceutical for $8 billion. But to do that, it'll need a loan, and it's agreed to a $9.275 billion loan package to back the acquisition. Deutsche Bank and Barclays have initially committed the financing, Reuters reports. Report | More